Dataset statistics
Number of variables | 15 |
---|---|
Number of observations | 2338 |
Missing cells | 647 |
Missing cells (%) | 1.8% |
Duplicate rows | 0 |
Duplicate rows (%) | 0.0% |
Total size in memory | 274.1 KiB |
Average record size in memory | 120.1 B |
Variable types
Categorical | 4 |
---|---|
Text | 8 |
DateTime | 3 |
Dataset
Description | CRIS는 질병의 예방(Prevention), 조기 발견 및 진단(Early Detection & Diagnosis), 예후(Prognosis), 치료(Treatment) 연구 등사람을 대상으로 하는 모든 연구가 등록 범위에 해당되며, 임상 시험 및 임상연구는 CRIS 등록 전에 각 기관연구윤리심의위원회(Insititutional Review Board)로부터 승인을 받아야 합니다. 또한 다기관연구인 경우에는 부정확한 정보 또는 이중 등록을 방지하기 위하여 책임 연구자의 소속기관에서 해당 연구 정보를 등록하여 하며, CRIS에 등록된 연구정보는 관리자의 승인시점부터 웹상에서 실시간으로 국내·외 대중에게 공개됩니다. CRIS의 운영 목적은 국내 임상시험과 임상연구의 정보 공유 및 윤리성, 투명성 확보에 있으며, 이를 통하여근거 중심의 의과학 연구기반을 마련하고자 합니다. |
---|---|
Author | 질병관리청 |
URL | https://www.data.go.kr/data/15083215/fileData.do |
중재종류 is highly overall correlated with 연구종류 | High correlation |
임상시험단계 is highly overall correlated with 연구종류 | High correlation |
연구종류 is highly overall correlated with 임상시험단계 and 1 other fields | High correlation |
연구대상/질환 has 82 (3.5%) missing values | Missing |
연구종료일 has 557 (23.8%) missing values | Missing |
등록번호 has unique values | Unique |
Reproduction
Analysis started | 2023-12-12 11:16:24.653061 |
---|---|
Analysis finished | 2023-12-12 11:16:29.547802 |
Duration | 4.89 seconds |
Software version | ydata-profiling vv4.5.1 |
Download configuration | config.json |
연구현황
Categorical
Distinct | 7 |
---|---|
Distinct (%) | 0.3% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
모집 중(Recruiting) | |
---|---|
연구종결(Completed) | |
대상자 모집 전(Not yet recruiting) | |
모집추가없이 진행중(Active, not recruiting) | |
모집중단(Terminated) | 16 |
Other values (2) | 15 |
Length
Max length | 34 |
---|---|
Median length | 28 |
Mean length | 17.804534 |
Min length | 15 |
Unique
Unique | 0 ? |
---|---|
Unique (%) | 0.0% |
Sample
1st row | 연구종결(Completed) |
---|---|
2nd row | 모집 중(Recruiting) |
3rd row | 연구종결(Completed) |
4th row | 모집 중(Recruiting) |
5th row | 모집 중(Recruiting) |
Common Values
Value | Count | Frequency (%) |
모집 중(Recruiting) | 1047 | |
연구종결(Completed) | 890 | |
대상자 모집 전(Not yet recruiting) | 256 | 10.9% |
모집추가없이 진행중(Active, not recruiting) | 114 | 4.9% |
모집중단(Terminated) | 16 | 0.7% |
연구철회(Withdrawn) | 13 | 0.6% |
일시중지(Suspended) | 2 | 0.1% |
Length
Common Values (Plot)
Value | Count | Frequency (%) |
모집 | 1303 | |
중(recruiting | 1047 | |
연구종결(completed | 890 | |
recruiting | 370 | 7.8% |
대상자 | 256 | 5.4% |
전(not | 256 | 5.4% |
yet | 256 | 5.4% |
모집추가없이 | 114 | 2.4% |
진행중(active | 114 | 2.4% |
not | 114 | 2.4% |
Other values (3) | 31 | 0.7% |
연구정보
Text
Distinct | 2330 |
---|---|
Distinct (%) | 99.7% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Length
Max length | 639 |
---|---|
Median length | 338 |
Mean length | 200.5201 |
Min length | 50 |
Characters and Unicode
Total characters | 468816 |
---|---|
Distinct characters | 840 |
Distinct categories | 17 ? |
Distinct scripts | 5 ? |
Distinct blocks | 12 ? |
Unique
Unique | 2325 ? |
---|---|
Unique (%) | 99.4% |
Sample
1st row | 건강한 남성 자원자에서 tadalafil 20 mg 정제와 tadalafil 20 mg 구강용해필름의 안전성과 약동학을 비교평가하기 위한 무작위배정, 공개, 단회 투여, 2X2 교차임상시험 - A randomized, open-label, single-dosing, two-treatment, two-sequence, two-period, 2x2 crossover study to evaluate the safety and pharmacokinetics of tadalafil 20 mg tablet and tadalafil 20 mg Oral Dissolving Film in healthy male volunteers |
---|---|
2nd row | 악성 식도 협착에서 자가 팽창형 금속제 스텐트의 유용성 : 새롭게 디자인 된 스텐트를 이용한 전향적 연구 - Usefulness of self-expanding metallic stent in malignant esophageal stricture: Prospective study using anti-migration stent newly-redesigned |
3rd row | 열공망막박리에서 충전물로서 공기를 사용한 결과 - Results of Exclusively Using Air as Gas Tamponade in Rhegmatogenous Retinal Detachment |
4th row | 유방암 환자로 항암치료에 수반되는 말초신경병증 환자에게 케어밴드(CarebandR)의 사용에 따른 효과 및 안전성 비교를 위한 단일기관, 무작위배정, 대조제품비교, 단일눈가림, 연구자 임상시험 - A Randomized, Single-blind, Placebo-controlled, Single center, Investigator Initiated Trial to Evaluate the Efficacy and Safety of CarebandR for Chemotherapy Induced Peripheral Neuropathy Subjects |
5th row | 경피적 관상동맥 중재술 및 프라수그렐 투여를 받은 급성 관상동맥 증후군 환자에서 1년간의 임상적 결과를 평가하기 위한 다기관, 비-중재적 관찰연구 - A multicenter, non-interventional observational study to evaluate 1-year clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) and Prasugrel therapy. |
Value | Count | Frequency (%) |
of | 2729 | 3.6% |
2632 | 3.5% | |
and | 1484 | 2.0% |
in | 1347 | 1.8% |
the | 1320 | 1.8% |
a | 928 | 1.2% |
study | 801 | 1.1% |
및 | 783 | 1.0% |
for | 764 | 1.0% |
위한 | 732 | 1.0% |
Other values (14711) | 61891 |
Most occurring characters
Value | Count | Frequency (%) |
73072 | 15.6% | |
e | 29359 | 6.3% |
i | 23500 | 5.0% |
a | 23252 | 5.0% |
t | 22738 | 4.9% |
o | 22611 | 4.8% |
n | 21065 | 4.5% |
r | 16738 | 3.6% |
s | 13959 | 3.0% |
l | 13919 | 3.0% |
Other values (830) | 208603 |
Most occurring categories
Value | Count | Frequency (%) |
Lowercase Letter | 267663 | |
Other Letter | 92041 | 19.6% |
Space Separator | 73073 | 15.6% |
Uppercase Letter | 19083 | 4.1% |
Other Punctuation | 5465 | 1.2% |
Dash Punctuation | 5209 | 1.1% |
Decimal Number | 4291 | 0.9% |
Open Punctuation | 907 | 0.2% |
Close Punctuation | 904 | 0.2% |
Initial Punctuation | 39 | < 0.1% |
Other values (7) | 141 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
의 | 2394 | 2.6% |
에 | 2307 | 2.5% |
성 | 2304 | 2.5% |
한 | 2120 | 2.3% |
위 | 1844 | 2.0% |
상 | 1671 | 1.8% |
자 | 1606 | 1.7% |
기 | 1556 | 1.7% |
시 | 1412 | 1.5% |
이 | 1319 | 1.4% |
Other values (717) | 73508 |
Lowercase Letter
Value | Count | Frequency (%) |
e | 29359 | |
i | 23500 | 8.8% |
a | 23252 | 8.7% |
t | 22738 | 8.5% |
o | 22611 | 8.4% |
n | 21065 | 7.9% |
r | 16738 | 6.3% |
s | 13959 | 5.2% |
l | 13919 | 5.2% |
c | 12439 | 4.6% |
Other values (20) | 68083 |
Uppercase Letter
Value | Count | Frequency (%) |
A | 1899 | 10.0% |
C | 1823 | 9.6% |
P | 1692 | 8.9% |
E | 1473 | 7.7% |
S | 1452 | 7.6% |
T | 1386 | 7.3% |
I | 1244 | 6.5% |
R | 1049 | 5.5% |
D | 1046 | 5.5% |
M | 893 | 4.7% |
Other values (17) | 5126 |
Other Punctuation
Value | Count | Frequency (%) |
, | 3923 | |
: | 680 | 12.4% |
/ | 290 | 5.3% |
. | 262 | 4.8% |
? | 110 | 2.0% |
; | 67 | 1.2% |
' | 48 | 0.9% |
% | 41 | 0.8% |
& | 24 | 0.4% |
· | 9 | 0.2% |
Other values (3) | 11 | 0.2% |
Decimal Number
Value | Count | Frequency (%) |
1 | 942 | |
2 | 868 | |
0 | 838 | |
3 | 428 | |
5 | 376 | 8.8% |
4 | 243 | 5.7% |
6 | 185 | 4.3% |
8 | 179 | 4.2% |
9 | 133 | 3.1% |
7 | 99 | 2.3% |
Math Symbol
Value | Count | Frequency (%) |
+ | 23 | |
< | 5 | 14.7% |
> | 2 | 5.9% |
~ | 2 | 5.9% |
= | 1 | 2.9% |
≤ | 1 | 2.9% |
Open Punctuation
Value | Count | Frequency (%) |
( | 894 | |
[ | 11 | 1.2% |
( | 1 | 0.1% |
「 | 1 | 0.1% |
Close Punctuation
Value | Count | Frequency (%) |
) | 891 | |
] | 11 | 1.2% |
) | 1 | 0.1% |
」 | 1 | 0.1% |
Other Symbol
Value | Count | Frequency (%) |
™ | 17 | |
㈜ | 8 | |
ⓡ | 5 | 16.1% |
㎍ | 1 | 3.2% |
Letter Number
Value | Count | Frequency (%) |
Ⅱ | 7 | |
Ⅰ | 5 | |
Ⅲ | 5 | |
Ⅳ | 2 | 10.5% |
Space Separator
Value | Count | Frequency (%) |
73072 | ||
1 | < 0.1% |
Dash Punctuation
Value | Count | Frequency (%) |
- | 5207 | |
― | 2 | < 0.1% |
Final Punctuation
Value | Count | Frequency (%) |
’ | 32 | |
” | 6 | 15.8% |
Initial Punctuation
Value | Count | Frequency (%) |
“ | 27 | |
‘ | 12 |
Connector Punctuation
Value | Count | Frequency (%) |
_ | 14 |
Format
Value | Count | Frequency (%) |
| 4 |
Modifier Symbol
Value | Count | Frequency (%) |
` | 1 |
Most occurring scripts
Value | Count | Frequency (%) |
Latin | 286728 | |
Hangul | 92033 | 19.6% |
Common | 90002 | 19.2% |
Greek | 37 | < 0.1% |
Han | 16 | < 0.1% |
Most frequent character per script
Hangul
Value | Count | Frequency (%) |
의 | 2394 | 2.6% |
에 | 2307 | 2.5% |
성 | 2304 | 2.5% |
한 | 2120 | 2.3% |
위 | 1844 | 2.0% |
상 | 1671 | 1.8% |
자 | 1606 | 1.7% |
기 | 1556 | 1.7% |
시 | 1412 | 1.5% |
이 | 1319 | 1.4% |
Other values (702) | 73500 |
Latin
Value | Count | Frequency (%) |
e | 29359 | 10.2% |
i | 23500 | 8.2% |
a | 23252 | 8.1% |
t | 22738 | 7.9% |
o | 22611 | 7.9% |
n | 21065 | 7.3% |
r | 16738 | 5.8% |
s | 13959 | 4.9% |
l | 13919 | 4.9% |
c | 12439 | 4.3% |
Other values (46) | 87148 |
Common
Value | Count | Frequency (%) |
73072 | ||
- | 5207 | 5.8% |
, | 3923 | 4.4% |
1 | 942 | 1.0% |
( | 894 | 1.0% |
) | 891 | 1.0% |
2 | 868 | 1.0% |
0 | 838 | 0.9% |
: | 680 | 0.8% |
3 | 428 | 0.5% |
Other values (41) | 2259 | 2.5% |
Han
Value | Count | Frequency (%) |
荊 | 1 | 6.2% |
芥 | 1 | 6.2% |
連 | 1 | 6.2% |
翹 | 1 | 6.2% |
湯 | 1 | 6.2% |
兪 | 1 | 6.2% |
胃 | 1 | 6.2% |
出 | 1 | 6.2% |
生 | 1 | 6.2% |
攝 | 1 | 6.2% |
Other values (6) | 6 |
Greek
Value | Count | Frequency (%) |
α | 16 | |
β | 13 | |
γ | 6 | 16.2% |
Ι | 1 | 2.7% |
μ | 1 | 2.7% |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 376589 | |
Hangul | 92022 | 19.6% |
Punctuation | 79 | < 0.1% |
None | 64 | < 0.1% |
Number Forms | 19 | < 0.1% |
Letterlike Symbols | 17 | < 0.1% |
CJK | 15 | < 0.1% |
Enclosed Alphanum | 5 | < 0.1% |
Compat Jamo | 3 | < 0.1% |
CJK Compat Ideographs | 1 | < 0.1% |
Other values (2) | 2 | < 0.1% |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
73072 | ||
e | 29359 | 7.8% |
i | 23500 | 6.2% |
a | 23252 | 6.2% |
t | 22738 | 6.0% |
o | 22611 | 6.0% |
n | 21065 | 5.6% |
r | 16738 | 4.4% |
s | 13959 | 3.7% |
l | 13919 | 3.7% |
Other values (76) | 116376 |
Hangul
Value | Count | Frequency (%) |
의 | 2394 | 2.6% |
에 | 2307 | 2.5% |
성 | 2304 | 2.5% |
한 | 2120 | 2.3% |
위 | 1844 | 2.0% |
상 | 1671 | 1.8% |
자 | 1606 | 1.7% |
기 | 1556 | 1.7% |
시 | 1412 | 1.5% |
이 | 1319 | 1.4% |
Other values (699) | 73489 |
Punctuation
Value | Count | Frequency (%) |
’ | 32 | |
“ | 27 | |
‘ | 12 | 15.2% |
” | 6 | 7.6% |
― | 2 | 2.5% |
Letterlike Symbols
Value | Count | Frequency (%) |
™ | 17 |
None
Value | Count | Frequency (%) |
α | 16 | |
β | 13 | |
· | 9 | |
㈜ | 8 | |
γ | 6 | 9.4% |
| 4 | 6.2% |
/ | 1 | 1.6% |
Ι | 1 | 1.6% |
μ | 1 | 1.6% |
( | 1 | 1.6% |
Other values (4) | 4 | 6.2% |
Number Forms
Value | Count | Frequency (%) |
Ⅱ | 7 | |
Ⅰ | 5 | |
Ⅲ | 5 | |
Ⅳ | 2 | 10.5% |
Enclosed Alphanum
Value | Count | Frequency (%) |
ⓡ | 5 |
Compat Jamo
Value | Count | Frequency (%) |
ㆍ | 2 | |
ㅡ | 1 |
CJK
Value | Count | Frequency (%) |
荊 | 1 | 6.7% |
芥 | 1 | 6.7% |
翹 | 1 | 6.7% |
湯 | 1 | 6.7% |
兪 | 1 | 6.7% |
胃 | 1 | 6.7% |
出 | 1 | 6.7% |
生 | 1 | 6.7% |
攝 | 1 | 6.7% |
統 | 1 | 6.7% |
Other values (5) | 5 |
CJK Compat Ideographs
Value | Count | Frequency (%) |
連 | 1 |
CJK Compat
Value | Count | Frequency (%) |
㎍ | 1 |
Math Operators
Value | Count | Frequency (%) |
≤ | 1 |
연구의뢰자
Text
Distinct | 233 |
---|---|
Distinct (%) | 10.0% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Length
Max length | 31 |
---|---|
Median length | 21 |
Mean length | 9.4923011 |
Min length | 2 |
Characters and Unicode
Total characters | 22193 |
---|---|
Distinct characters | 195 |
Distinct categories | 7 ? |
Distinct scripts | 3 ? |
Distinct blocks | 2 ? |
Unique
Unique | 66 ? |
---|---|
Unique (%) | 2.8% |
Sample
1st row | 충남대학교병원 |
---|---|
2nd row | 재단법인아산사회복지재단 서울아산병원 |
3rd row | 부산대학교병원 |
4th row | 충남대학교 |
5th row | 서울대학교병원 |
Value | Count | Frequency (%) |
서울아산병원 | 207 | 8.4% |
서울대학교병원 | 184 | 7.5% |
분당서울대학교병원 | 130 | 5.3% |
사)삼성생명공익재단삼성서울병원 | 78 | 3.2% |
건국대학교병원 | 65 | 2.6% |
가톨릭대학교서울성모병원 | 56 | 2.3% |
아주대학교병원 | 54 | 2.2% |
연세대학교의과대학세브란스병원 | 50 | 2.0% |
전북대학교병원 | 50 | 2.0% |
한양대학교병원 | 39 | 1.6% |
Other values (251) | 1556 |
Most occurring characters
Value | Count | Frequency (%) |
학 | 2162 | 9.7% |
대 | 2130 | 9.6% |
원 | 2115 | 9.5% |
병 | 1910 | 8.6% |
교 | 1860 | 8.4% |
울 | 821 | 3.7% |
서 | 809 | 3.6% |
성 | 419 | 1.9% |
산 | 415 | 1.9% |
의 | 363 | 1.6% |
Other values (185) | 9189 |
Most occurring categories
Value | Count | Frequency (%) |
Other Letter | 21829 | |
Space Separator | 131 | 0.6% |
Open Punctuation | 108 | 0.5% |
Close Punctuation | 108 | 0.5% |
Lowercase Letter | 10 | < 0.1% |
Other Punctuation | 4 | < 0.1% |
Uppercase Letter | 3 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
학 | 2162 | 9.9% |
대 | 2130 | 9.8% |
원 | 2115 | 9.7% |
병 | 1910 | 8.7% |
교 | 1860 | 8.5% |
울 | 821 | 3.8% |
서 | 809 | 3.7% |
성 | 419 | 1.9% |
산 | 415 | 1.9% |
의 | 363 | 1.7% |
Other values (169) | 8825 |
Lowercase Letter
Value | Count | Frequency (%) |
o | 3 | |
i | 2 | |
d | 1 | 10.0% |
g | 1 | 10.0% |
t | 1 | 10.0% |
n | 1 | 10.0% |
h | 1 | 10.0% |
Other Punctuation
Value | Count | Frequency (%) |
. | 2 | |
, | 1 | |
& | 1 |
Uppercase Letter
Value | Count | Frequency (%) |
L | 1 | |
C | 1 | |
S | 1 |
Space Separator
Value | Count | Frequency (%) |
131 |
Open Punctuation
Value | Count | Frequency (%) |
( | 108 |
Close Punctuation
Value | Count | Frequency (%) |
) | 108 |
Most occurring scripts
Value | Count | Frequency (%) |
Hangul | 21829 | |
Common | 351 | 1.6% |
Latin | 13 | 0.1% |
Most frequent character per script
Hangul
Value | Count | Frequency (%) |
학 | 2162 | 9.9% |
대 | 2130 | 9.8% |
원 | 2115 | 9.7% |
병 | 1910 | 8.7% |
교 | 1860 | 8.5% |
울 | 821 | 3.8% |
서 | 809 | 3.7% |
성 | 419 | 1.9% |
산 | 415 | 1.9% |
의 | 363 | 1.7% |
Other values (169) | 8825 |
Latin
Value | Count | Frequency (%) |
o | 3 | |
i | 2 | |
d | 1 | 7.7% |
g | 1 | 7.7% |
t | 1 | 7.7% |
L | 1 | 7.7% |
C | 1 | 7.7% |
n | 1 | 7.7% |
h | 1 | 7.7% |
S | 1 | 7.7% |
Common
Value | Count | Frequency (%) |
131 | ||
( | 108 | |
) | 108 | |
. | 2 | 0.6% |
, | 1 | 0.3% |
& | 1 | 0.3% |
Most occurring blocks
Value | Count | Frequency (%) |
Hangul | 21829 | |
ASCII | 364 | 1.6% |
Most frequent character per block
Hangul
Value | Count | Frequency (%) |
학 | 2162 | 9.9% |
대 | 2130 | 9.8% |
원 | 2115 | 9.7% |
병 | 1910 | 8.7% |
교 | 1860 | 8.5% |
울 | 821 | 3.8% |
서 | 809 | 3.7% |
성 | 419 | 1.9% |
산 | 415 | 1.9% |
의 | 363 | 1.7% |
Other values (169) | 8825 |
ASCII
Value | Count | Frequency (%) |
131 | ||
( | 108 | |
) | 108 | |
o | 3 | 0.8% |
. | 2 | 0.5% |
i | 2 | 0.5% |
d | 1 | 0.3% |
g | 1 | 0.3% |
t | 1 | 0.3% |
L | 1 | 0.3% |
Other values (6) | 6 | 1.6% |
연구비지원기관
Text
Distinct | 531 |
---|---|
Distinct (%) | 22.7% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Length
Max length | 231 |
---|---|
Median length | 96.5 |
Mean length | 40.894354 |
Min length | 4 |
Characters and Unicode
Total characters | 95611 |
---|---|
Distinct characters | 401 |
Distinct categories | 11 ? |
Distinct scripts | 3 ? |
Distinct blocks | 4 ? |
Unique
Unique | 306 ? |
---|---|
Unique (%) | 13.1% |
Sample
1st row | (주)씨엘팜(CLPharm) |
---|---|
2nd row | 재단법인아산사회복지재단 서울아산병원(Asan Medical Center) |
3rd row | 부산대학교병원(Pusan National University Hospital) |
4th row | 보건복지부(Ministry of Health & Welfare) |
5th row | 한국다이이찌산쿄 주식회사(Daiichi-Sankyo Korea) |
Value | Count | Frequency (%) |
university | 779 | 7.7% |
666 | 6.6% | |
of | 616 | 6.1% |
hospital | 565 | 5.6% |
medical | 394 | 3.9% |
center | 349 | 3.4% |
health | 331 | 3.3% |
welfare | 274 | 2.7% |
national | 269 | 2.7% |
보건복지부(ministry | 268 | 2.6% |
Other values (883) | 5605 |
Most occurring characters
Value | Count | Frequency (%) |
7778 | 8.1% | |
e | 6318 | 6.6% |
i | 5646 | 5.9% |
a | 5351 | 5.6% |
n | 5181 | 5.4% |
t | 4589 | 4.8% |
o | 4035 | 4.2% |
r | 3715 | 3.9% |
l | 3252 | 3.4% |
s | 2970 | 3.1% |
Other values (391) | 46776 |
Most occurring categories
Value | Count | Frequency (%) |
Lowercase Letter | 53134 | |
Other Letter | 18777 | 19.6% |
Uppercase Letter | 9142 | 9.6% |
Space Separator | 7778 | 8.1% |
Close Punctuation | 2931 | 3.1% |
Open Punctuation | 2931 | 3.1% |
Other Punctuation | 792 | 0.8% |
Dash Punctuation | 121 | 0.1% |
Other Symbol | 2 | < 0.1% |
Decimal Number | 2 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
원 | 1254 | 6.7% |
학 | 1158 | 6.2% |
병 | 945 | 5.0% |
대 | 926 | 4.9% |
교 | 835 | 4.4% |
한 | 623 | 3.3% |
주 | 596 | 3.2% |
부 | 508 | 2.7% |
국 | 424 | 2.3% |
건 | 410 | 2.2% |
Other values (327) | 11098 |
Lowercase Letter
Value | Count | Frequency (%) |
e | 6318 | |
i | 5646 | |
a | 5351 | |
n | 5181 | |
t | 4589 | |
o | 4035 | 7.6% |
r | 3715 | 7.0% |
l | 3252 | 6.1% |
s | 2970 | 5.6% |
y | 1684 | 3.2% |
Other values (15) | 10393 |
Uppercase Letter
Value | Count | Frequency (%) |
H | 1170 | |
M | 1047 | |
C | 993 | |
U | 838 | |
K | 716 | 7.8% |
S | 706 | 7.7% |
A | 427 | 4.7% |
I | 425 | 4.6% |
N | 407 | 4.5% |
P | 367 | 4.0% |
Other values (15) | 2046 |
Other Punctuation
Value | Count | Frequency (%) |
& | 395 | |
, | 225 | |
. | 93 | 11.7% |
' | 77 | 9.7% |
# | 1 | 0.1% |
/ | 1 | 0.1% |
Decimal Number
Value | Count | Frequency (%) |
3 | 1 | |
1 | 1 |
Space Separator
Value | Count | Frequency (%) |
7778 |
Close Punctuation
Value | Count | Frequency (%) |
) | 2931 |
Open Punctuation
Value | Count | Frequency (%) |
( | 2931 |
Dash Punctuation
Value | Count | Frequency (%) |
- | 121 |
Other Symbol
Value | Count | Frequency (%) |
㈜ | 2 |
Final Punctuation
Value | Count | Frequency (%) |
’ | 1 |
Most occurring scripts
Value | Count | Frequency (%) |
Latin | 62276 | |
Hangul | 18779 | 19.6% |
Common | 14556 | 15.2% |
Most frequent character per script
Hangul
Value | Count | Frequency (%) |
원 | 1254 | 6.7% |
학 | 1158 | 6.2% |
병 | 945 | 5.0% |
대 | 926 | 4.9% |
교 | 835 | 4.4% |
한 | 623 | 3.3% |
주 | 596 | 3.2% |
부 | 508 | 2.7% |
국 | 424 | 2.3% |
건 | 410 | 2.2% |
Other values (328) | 11100 |
Latin
Value | Count | Frequency (%) |
e | 6318 | 10.1% |
i | 5646 | 9.1% |
a | 5351 | 8.6% |
n | 5181 | 8.3% |
t | 4589 | 7.4% |
o | 4035 | 6.5% |
r | 3715 | 6.0% |
l | 3252 | 5.2% |
s | 2970 | 4.8% |
y | 1684 | 2.7% |
Other values (40) | 19535 |
Common
Value | Count | Frequency (%) |
7778 | ||
) | 2931 | 20.1% |
( | 2931 | 20.1% |
& | 395 | 2.7% |
, | 225 | 1.5% |
- | 121 | 0.8% |
. | 93 | 0.6% |
' | 77 | 0.5% |
3 | 1 | < 0.1% |
# | 1 | < 0.1% |
Other values (3) | 3 | < 0.1% |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 76831 | |
Hangul | 18777 | 19.6% |
None | 2 | < 0.1% |
Punctuation | 1 | < 0.1% |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
7778 | 10.1% | |
e | 6318 | 8.2% |
i | 5646 | 7.3% |
a | 5351 | 7.0% |
n | 5181 | 6.7% |
t | 4589 | 6.0% |
o | 4035 | 5.3% |
r | 3715 | 4.8% |
l | 3252 | 4.2% |
s | 2970 | 3.9% |
Other values (52) | 27996 |
Hangul
Value | Count | Frequency (%) |
원 | 1254 | 6.7% |
학 | 1158 | 6.2% |
병 | 945 | 5.0% |
대 | 926 | 4.9% |
교 | 835 | 4.4% |
한 | 623 | 3.3% |
주 | 596 | 3.2% |
부 | 508 | 2.7% |
국 | 424 | 2.3% |
건 | 410 | 2.2% |
Other values (327) | 11098 |
None
Value | Count | Frequency (%) |
㈜ | 2 |
Punctuation
Value | Count | Frequency (%) |
’ | 1 |
연구종류
Categorical
HIGH CORRELATION
 
Distinct | 2 |
---|---|
Distinct (%) | 0.1% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
중재연구(Interventional Study) | |
---|---|
관찰연구(Observational Study) |
Length
Max length | 26 |
---|---|
Median length | 26 |
Mean length | 25.720274 |
Min length | 25 |
Unique
Unique | 0 ? |
---|---|
Unique (%) | 0.0% |
Sample
1st row | 중재연구(Interventional Study) |
---|---|
2nd row | 중재연구(Interventional Study) |
3rd row | 중재연구(Interventional Study) |
4th row | 중재연구(Interventional Study) |
5th row | 관찰연구(Observational Study) |
Common Values
Value | Count | Frequency (%) |
중재연구(Interventional Study) | 1684 | |
관찰연구(Observational Study) | 654 | 28.0% |
Length
Common Values (Plot)
Value | Count | Frequency (%) |
study | 2338 | |
중재연구(interventional | 1684 | |
관찰연구(observational | 654 | 14.0% |
임상시험단계
Categorical
HIGH CORRELATION
 
Distinct | 9 |
---|---|
Distinct (%) | 0.4% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
해당사항없음(Not applicable) | |
---|---|
<NA> | |
Phase1 | |
Phase4 | |
Phase3 | |
Other values (4) |
Length
Max length | 22 |
---|---|
Median length | 13 |
Mean length | 12.048332 |
Min length | 4 |
Unique
Unique | 0 ? |
---|---|
Unique (%) | 0.0% |
Sample
1st row | Phase1 |
---|---|
2nd row | Phase1 |
3rd row | 해당사항없음(Not applicable) |
4th row | 해당사항없음(Not applicable) |
5th row | <NA> |
Common Values
Value | Count | Frequency (%) |
해당사항없음(Not applicable) | 945 | |
<NA> | 654 | |
Phase1 | 221 | 9.5% |
Phase4 | 210 | 9.0% |
Phase3 | 156 | 6.7% |
Phase2 | 103 | 4.4% |
Phase1/Phase2 | 29 | 1.2% |
Phase2/Phase3 | 18 | 0.8% |
Phase0 | 2 | 0.1% |
Length
Common Values (Plot)
Value | Count | Frequency (%) |
해당사항없음(not | 945 | |
applicable | 945 | |
na | 654 | |
phase1 | 221 | 6.7% |
phase4 | 210 | 6.4% |
phase3 | 156 | 4.8% |
phase2 | 103 | 3.1% |
phase1/phase2 | 29 | 0.9% |
phase2/phase3 | 18 | 0.5% |
phase0 | 2 | 0.1% |
중재종류
Categorical
HIGH CORRELATION
 
Distinct | 34 |
---|---|
Distinct (%) | 1.5% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
의약품(Drug) | |
---|---|
<NA> | |
의료기구(Medical Device) | |
시술/수술(Procedure/Surgery) | |
식이보충제(Dietary Supplement) | |
Other values (29) |
Length
Max length | 91 |
---|---|
Median length | 76 |
Mean length | 13.64414 |
Min length | 4 |
Unique
Unique | 6 ? |
---|---|
Unique (%) | 0.3% |
Sample
1st row | 의약품(Drug) |
---|---|
2nd row | 의료기구(Medical Device) |
3rd row | 시술/수술(Procedure/Surgery) |
4th row | 의료기구(Medical Device) |
5th row | <NA> |
Common Values
Value | Count | Frequency (%) |
의약품(Drug) | 749 | |
<NA> | 654 | |
의료기구(Medical Device) | 224 | 9.6% |
시술/수술(Procedure/Surgery) | 223 | 9.5% |
식이보충제(Dietary Supplement) | 144 | 6.2% |
기타(Others) | 130 | 5.6% |
행동요인(Behavioral) | 51 | 2.2% |
생물학적제제/백신(Biological/Vaccine), 줄기세포를 제외한 생물학적제제/백신(Non-Stem Cell) | 33 | 1.4% |
의료기구(Medical Device), 시술/수술(Procedure/Surgery) | 24 | 1.0% |
의약품(Drug), 의료기구(Medical Device) | 15 | 0.6% |
Other values (24) | 91 | 3.9% |
Length
Value | Count | Frequency (%) |
의약품(drug | 802 | |
na | 654 | |
시술/수술(procedure/surgery | 274 | 9.0% |
의료기구(medical | 270 | 8.9% |
device | 270 | 8.9% |
기타(others | 151 | 5.0% |
식이보충제(dietary | 146 | 4.8% |
supplement | 146 | 4.8% |
생물학적제제/백신(biological/vaccine | 67 | 2.2% |
행동요인(behavioral | 60 | 2.0% |
Other values (7) | 189 | 6.2% |
등록번호
Text
UNIQUE
 
Distinct | 2338 |
---|---|
Distinct (%) | 100.0% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Length
Max length | 10 |
---|---|
Median length | 10 |
Mean length | 10 |
Min length | 10 |
Characters and Unicode
Total characters | 23380 |
---|---|
Distinct characters | 13 |
Distinct categories | 2 ? |
Distinct scripts | 2 ? |
Distinct blocks | 1 ? |
Unique
Unique | 2338 ? |
---|---|
Unique (%) | 100.0% |
Sample
1st row | KCT0002360 |
---|---|
2nd row | KCT0002359 |
3rd row | KCT0002358 |
4th row | KCT0002357 |
5th row | KCT0002356 |
Value | Count | Frequency (%) |
kct0002360 | 1 | < 0.1% |
kct0000780 | 1 | < 0.1% |
kct0000795 | 1 | < 0.1% |
kct0000794 | 1 | < 0.1% |
kct0000787 | 1 | < 0.1% |
kct0000793 | 1 | < 0.1% |
kct0000792 | 1 | < 0.1% |
kct0000791 | 1 | < 0.1% |
kct0000790 | 1 | < 0.1% |
kct0000789 | 1 | < 0.1% |
Other values (2328) | 2328 |
Most occurring characters
Value | Count | Frequency (%) |
0 | 8768 | |
K | 2338 | 10.0% |
C | 2338 | 10.0% |
T | 2338 | 10.0% |
1 | 1761 | 7.5% |
2 | 1128 | 4.8% |
3 | 731 | 3.1% |
4 | 669 | 2.9% |
5 | 669 | 2.9% |
8 | 662 | 2.8% |
Other values (3) | 1978 | 8.5% |
Most occurring categories
Value | Count | Frequency (%) |
Decimal Number | 16366 | |
Uppercase Letter | 7014 |
Most frequent character per category
Decimal Number
Value | Count | Frequency (%) |
0 | 8768 | |
1 | 1761 | 10.8% |
2 | 1128 | 6.9% |
3 | 731 | 4.5% |
4 | 669 | 4.1% |
5 | 669 | 4.1% |
8 | 662 | 4.0% |
9 | 661 | 4.0% |
7 | 659 | 4.0% |
6 | 658 | 4.0% |
Uppercase Letter
Value | Count | Frequency (%) |
K | 2338 | |
C | 2338 | |
T | 2338 |
Most occurring scripts
Value | Count | Frequency (%) |
Common | 16366 | |
Latin | 7014 |
Most frequent character per script
Common
Value | Count | Frequency (%) |
0 | 8768 | |
1 | 1761 | 10.8% |
2 | 1128 | 6.9% |
3 | 731 | 4.5% |
4 | 669 | 4.1% |
5 | 669 | 4.1% |
8 | 662 | 4.0% |
9 | 661 | 4.0% |
7 | 659 | 4.0% |
6 | 658 | 4.0% |
Latin
Value | Count | Frequency (%) |
K | 2338 | |
C | 2338 | |
T | 2338 |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 23380 |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
0 | 8768 | |
K | 2338 | 10.0% |
C | 2338 | 10.0% |
T | 2338 | 10.0% |
1 | 1761 | 7.5% |
2 | 1128 | 4.8% |
3 | 731 | 3.1% |
4 | 669 | 2.9% |
5 | 669 | 2.9% |
8 | 662 | 2.8% |
Other values (3) | 1978 | 8.5% |
연구고유번호
Text
Distinct | 2319 |
---|---|
Distinct (%) | 99.3% |
Missing | 2 |
Missing (%) | 0.1% |
Memory size | 18.4 KiB |
Length
Max length | 35 |
---|---|
Median length | 27 |
Mean length | 12.302654 |
Min length | 1 |
Characters and Unicode
Total characters | 28739 |
---|---|
Distinct characters | 103 |
Distinct categories | 12 ? |
Distinct scripts | 3 ? |
Distinct blocks | 3 ? |
Unique
Unique | 2305 ? |
---|---|
Unique (%) | 98.7% |
Sample
1st row | CNUH 2014-08-014 |
---|---|
2nd row | 2016-0471 |
3rd row | H-1612-005-049 |
4th row | CNUH 2016-11-020-004 |
5th row | EFT-OS-16-01 |
Value | Count | Frequency (%) |
irb | 44 | 1.6% |
hyuh | 30 | 1.1% |
smc | 30 | 1.1% |
kmc | 21 | 0.8% |
cuh | 16 | 0.6% |
cnuh | 12 | 0.4% |
eumc | 12 | 0.4% |
kuh | 8 | 0.3% |
emc | 8 | 0.3% |
knuh | 8 | 0.3% |
Other values (2390) | 2487 |
Most occurring characters
Value | Count | Frequency (%) |
0 | 5004 | |
1 | 4130 | |
- | 3593 | |
2 | 2459 | 8.6% |
3 | 1083 | 3.8% |
4 | 1077 | 3.7% |
5 | 901 | 3.1% |
6 | 888 | 3.1% |
C | 806 | 2.8% |
H | 673 | 2.3% |
Other values (93) | 8125 |
Most occurring categories
Value | Count | Frequency (%) |
Decimal Number | 17104 | |
Uppercase Letter | 6874 | |
Dash Punctuation | 3593 | 12.5% |
Lowercase Letter | 394 | 1.4% |
Space Separator | 340 | 1.2% |
Connector Punctuation | 153 | 0.5% |
Other Punctuation | 116 | 0.4% |
Other Letter | 84 | 0.3% |
Open Punctuation | 38 | 0.1% |
Close Punctuation | 38 | 0.1% |
Other values (2) | 5 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
임 | 10 | 11.9% |
제 | 7 | 8.3% |
상 | 7 | 8.3% |
호 | 6 | 7.1% |
명 | 3 | 3.6% |
삼 | 3 | 3.6% |
정 | 3 | 3.6% |
일 | 3 | 3.6% |
생 | 3 | 3.6% |
보 | 3 | 3.6% |
Other values (21) | 36 |
Uppercase Letter
Value | Count | Frequency (%) |
C | 806 | |
H | 673 | 9.8% |
I | 629 | 9.2% |
B | 516 | 7.5% |
M | 493 | 7.2% |
R | 442 | 6.4% |
K | 440 | 6.4% |
S | 395 | 5.7% |
D | 342 | 5.0% |
U | 329 | 4.8% |
Other values (16) | 1809 |
Lowercase Letter
Value | Count | Frequency (%) |
e | 48 | |
a | 47 | |
o | 39 | 9.9% |
n | 31 | 7.9% |
i | 28 | 7.1% |
r | 26 | 6.6% |
l | 22 | 5.6% |
u | 21 | 5.3% |
c | 18 | 4.6% |
s | 14 | 3.6% |
Other values (15) | 100 |
Decimal Number
Value | Count | Frequency (%) |
0 | 5004 | |
1 | 4130 | |
2 | 2459 | |
3 | 1083 | 6.3% |
4 | 1077 | 6.3% |
5 | 901 | 5.3% |
6 | 888 | 5.2% |
7 | 571 | 3.3% |
9 | 503 | 2.9% |
8 | 488 | 2.9% |
Other Punctuation
Value | Count | Frequency (%) |
/ | 101 | |
. | 14 | 12.1% |
: | 1 | 0.9% |
Math Symbol
Value | Count | Frequency (%) |
+ | 2 | |
| | 1 |
Dash Punctuation
Value | Count | Frequency (%) |
- | 3593 |
Space Separator
Value | Count | Frequency (%) |
340 |
Connector Punctuation
Value | Count | Frequency (%) |
_ | 153 |
Open Punctuation
Value | Count | Frequency (%) |
( | 38 |
Close Punctuation
Value | Count | Frequency (%) |
) | 38 |
Letter Number
Value | Count | Frequency (%) |
Ⅱ | 2 |
Most occurring scripts
Value | Count | Frequency (%) |
Common | 21385 | |
Latin | 7270 | 25.3% |
Hangul | 84 | 0.3% |
Most frequent character per script
Latin
Value | Count | Frequency (%) |
C | 806 | 11.1% |
H | 673 | 9.3% |
I | 629 | 8.7% |
B | 516 | 7.1% |
M | 493 | 6.8% |
R | 442 | 6.1% |
K | 440 | 6.1% |
S | 395 | 5.4% |
D | 342 | 4.7% |
U | 329 | 4.5% |
Other values (42) | 2205 |
Hangul
Value | Count | Frequency (%) |
임 | 10 | 11.9% |
제 | 7 | 8.3% |
상 | 7 | 8.3% |
호 | 6 | 7.1% |
명 | 3 | 3.6% |
삼 | 3 | 3.6% |
정 | 3 | 3.6% |
일 | 3 | 3.6% |
생 | 3 | 3.6% |
보 | 3 | 3.6% |
Other values (21) | 36 |
Common
Value | Count | Frequency (%) |
0 | 5004 | |
1 | 4130 | |
- | 3593 | |
2 | 2459 | |
3 | 1083 | 5.1% |
4 | 1077 | 5.0% |
5 | 901 | 4.2% |
6 | 888 | 4.2% |
7 | 571 | 2.7% |
9 | 503 | 2.4% |
Other values (10) | 1176 | 5.5% |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 28653 | |
Hangul | 84 | 0.3% |
Number Forms | 2 | < 0.1% |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
0 | 5004 | |
1 | 4130 | |
- | 3593 | |
2 | 2459 | 8.6% |
3 | 1083 | 3.8% |
4 | 1077 | 3.8% |
5 | 901 | 3.1% |
6 | 888 | 3.1% |
C | 806 | 2.8% |
H | 673 | 2.3% |
Other values (61) | 8039 |
Hangul
Value | Count | Frequency (%) |
임 | 10 | 11.9% |
제 | 7 | 8.3% |
상 | 7 | 8.3% |
호 | 6 | 7.1% |
명 | 3 | 3.6% |
삼 | 3 | 3.6% |
정 | 3 | 3.6% |
일 | 3 | 3.6% |
생 | 3 | 3.6% |
보 | 3 | 3.6% |
Other values (21) | 36 |
Number Forms
Value | Count | Frequency (%) |
Ⅱ | 2 |
연구대상/질환
Text
MISSING
 
Distinct | 1860 |
---|---|
Distinct (%) | 82.4% |
Missing | 82 |
Missing (%) | 3.5% |
Memory size | 18.4 KiB |
Length
Max length | 1024 |
---|---|
Median length | 294 |
Mean length | 44.007535 |
Min length | 1 |
Characters and Unicode
Total characters | 99281 |
---|---|
Distinct characters | 627 |
Distinct categories | 15 ? |
Distinct scripts | 4 ? |
Distinct blocks | 8 ? |
Unique
Unique | 1662 ? |
---|---|
Unique (%) | 73.7% |
Sample
1st row | penile erection |
---|---|
2nd row | Obstructive, Stents |
3rd row | Retinal Detachment |
4th row | Breast Neoplasms Peripheral Nervous System Diseases |
5th row | Acute Coronary Syndrome |
Value | Count | Frequency (%) |
환자 | 253 | 1.7% |
of | 168 | 1.1% |
disease | 110 | 0.7% |
및 | 106 | 0.7% |
and | 106 | 0.7% |
the | 96 | 0.6% |
건강한 | 95 | 0.6% |
94 | 0.6% | |
성인 | 92 | 0.6% |
or | 87 | 0.6% |
Other values (5361) | 14083 |
Most occurring characters
Value | Count | Frequency (%) |
13026 | 13.1% | |
e | 6132 | 6.2% |
i | 5064 | 5.1% |
a | 4623 | 4.7% |
t | 4160 | 4.2% |
o | 3970 | 4.0% |
r | 3950 | 4.0% |
s | 3937 | 4.0% |
n | 3456 | 3.5% |
l | 2714 | 2.7% |
Other values (617) | 48249 |
Most occurring categories
Value | Count | Frequency (%) |
Lowercase Letter | 53292 | |
Other Letter | 22584 | |
Space Separator | 13035 | 13.1% |
Uppercase Letter | 4094 | 4.1% |
Decimal Number | 2294 | 2.3% |
Other Punctuation | 1964 | 2.0% |
Close Punctuation | 866 | 0.9% |
Open Punctuation | 837 | 0.8% |
Dash Punctuation | 250 | 0.3% |
Math Symbol | 48 | < 0.1% |
Other values (5) | 17 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
성 | 734 | 3.3% |
이 | 612 | 2.7% |
자 | 604 | 2.7% |
상 | 566 | 2.5% |
환 | 519 | 2.3% |
는 | 464 | 2.1% |
의 | 419 | 1.9% |
한 | 342 | 1.5% |
인 | 332 | 1.5% |
로 | 317 | 1.4% |
Other values (517) | 17675 |
Lowercase Letter
Value | Count | Frequency (%) |
e | 6132 | |
i | 5064 | |
a | 4623 | 8.7% |
t | 4160 | 7.8% |
o | 3970 | 7.4% |
r | 3950 | 7.4% |
s | 3937 | 7.4% |
n | 3456 | 6.5% |
l | 2714 | 5.1% |
c | 2633 | 4.9% |
Other values (17) | 12653 |
Uppercase Letter
Value | Count | Frequency (%) |
C | 434 | 10.6% |
S | 361 | 8.8% |
A | 351 | 8.6% |
P | 304 | 7.4% |
I | 298 | 7.3% |
D | 273 | 6.7% |
H | 271 | 6.6% |
M | 220 | 5.4% |
B | 205 | 5.0% |
T | 187 | 4.6% |
Other values (16) | 1190 |
Other Punctuation
Value | Count | Frequency (%) |
, | 1165 | |
. | 546 | |
/ | 95 | 4.8% |
: | 66 | 3.4% |
; | 53 | 2.7% |
' | 16 | 0.8% |
% | 7 | 0.4% |
· | 7 | 0.4% |
* | 5 | 0.3% |
& | 3 | 0.2% |
Decimal Number
Value | Count | Frequency (%) |
0 | 483 | |
1 | 364 | |
2 | 343 | |
5 | 293 | |
3 | 167 | 7.3% |
6 | 161 | 7.0% |
8 | 130 | 5.7% |
7 | 125 | 5.4% |
4 | 119 | 5.2% |
9 | 109 | 4.8% |
Math Symbol
Value | Count | Frequency (%) |
~ | 22 | |
≥ | 7 | 14.6% |
> | 6 | 12.5% |
+ | 5 | 10.4% |
± | 3 | 6.2% |
< | 2 | 4.2% |
≤ | 2 | 4.2% |
= | 1 | 2.1% |
Letter Number
Value | Count | Frequency (%) |
Ⅳ | 2 | |
Ⅰ | 2 | |
Ⅲ | 2 | |
Ⅱ | 1 | |
Ⅴ | 1 |
Space Separator
Value | Count | Frequency (%) |
13026 | ||
9 | 0.1% |
Close Punctuation
Value | Count | Frequency (%) |
) | 768 | |
] | 98 | 11.3% |
Open Punctuation
Value | Count | Frequency (%) |
( | 739 | |
[ | 98 | 11.7% |
Dash Punctuation
Value | Count | Frequency (%) |
- | 248 | |
- | 2 | 0.8% |
Other Symbol
Value | Count | Frequency (%) |
■ | 2 | |
○ | 1 |
Final Punctuation
Value | Count | Frequency (%) |
’ | 4 |
Initial Punctuation
Value | Count | Frequency (%) |
‘ | 1 |
Modifier Symbol
Value | Count | Frequency (%) |
^ | 1 |
Most occurring scripts
Value | Count | Frequency (%) |
Latin | 57393 | |
Hangul | 22584 | 22.7% |
Common | 19303 | 19.4% |
Greek | 1 | < 0.1% |
Most frequent character per script
Hangul
Value | Count | Frequency (%) |
성 | 734 | 3.3% |
이 | 612 | 2.7% |
자 | 604 | 2.7% |
상 | 566 | 2.5% |
환 | 519 | 2.3% |
는 | 464 | 2.1% |
의 | 419 | 1.9% |
한 | 342 | 1.5% |
인 | 332 | 1.5% |
로 | 317 | 1.4% |
Other values (517) | 17675 |
Latin
Value | Count | Frequency (%) |
e | 6132 | 10.7% |
i | 5064 | 8.8% |
a | 4623 | 8.1% |
t | 4160 | 7.2% |
o | 3970 | 6.9% |
r | 3950 | 6.9% |
s | 3937 | 6.9% |
n | 3456 | 6.0% |
l | 2714 | 4.7% |
c | 2633 | 4.6% |
Other values (47) | 16754 |
Common
Value | Count | Frequency (%) |
13026 | ||
, | 1165 | 6.0% |
) | 768 | 4.0% |
( | 739 | 3.8% |
. | 546 | 2.8% |
0 | 483 | 2.5% |
1 | 364 | 1.9% |
2 | 343 | 1.8% |
5 | 293 | 1.5% |
- | 248 | 1.3% |
Other values (32) | 1328 | 6.9% |
Greek
Value | Count | Frequency (%) |
α | 1 |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 76649 | |
Hangul | 22570 | 22.7% |
None | 23 | < 0.1% |
Compat Jamo | 14 | < 0.1% |
Math Operators | 9 | < 0.1% |
Number Forms | 8 | < 0.1% |
Punctuation | 5 | < 0.1% |
Geometric Shapes | 3 | < 0.1% |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
13026 | ||
e | 6132 | 8.0% |
i | 5064 | 6.6% |
a | 4623 | 6.0% |
t | 4160 | 5.4% |
o | 3970 | 5.2% |
r | 3950 | 5.2% |
s | 3937 | 5.1% |
n | 3456 | 4.5% |
l | 2714 | 3.5% |
Other values (73) | 25617 |
Hangul
Value | Count | Frequency (%) |
성 | 734 | 3.3% |
이 | 612 | 2.7% |
자 | 604 | 2.7% |
상 | 566 | 2.5% |
환 | 519 | 2.3% |
는 | 464 | 2.1% |
의 | 419 | 1.9% |
한 | 342 | 1.5% |
인 | 332 | 1.5% |
로 | 317 | 1.4% |
Other values (514) | 17661 |
None
Value | Count | Frequency (%) |
9 | ||
· | 7 | |
± | 3 | 13.0% |
- | 2 | 8.7% |
α | 1 | 4.3% |
. | 1 | 4.3% |
Math Operators
Value | Count | Frequency (%) |
≥ | 7 | |
≤ | 2 | 22.2% |
Compat Jamo
Value | Count | Frequency (%) |
ㄷ | 5 | |
ㄱ | 5 | |
ㄴ | 4 |
Punctuation
Value | Count | Frequency (%) |
’ | 4 | |
‘ | 1 | 20.0% |
Geometric Shapes
Value | Count | Frequency (%) |
■ | 2 | |
○ | 1 |
Number Forms
Value | Count | Frequency (%) |
Ⅳ | 2 | |
Ⅰ | 2 | |
Ⅲ | 2 | |
Ⅱ | 1 | |
Ⅴ | 1 |
등록일
Date
Distinct | 1000 |
---|---|
Distinct (%) | 42.8% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Minimum | 2010-02-11 00:00:00 |
---|---|
Maximum | 2017-06-15 00:00:00 |
최종갱신일
Date
Distinct | 1210 |
---|---|
Distinct (%) | 51.8% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Minimum | 2010-04-07 00:00:00 |
---|---|
Maximum | 2017-06-19 00:00:00 |
첫환자등록일자
Date
Distinct | 1372 |
---|---|
Distinct (%) | 58.8% |
Missing | 6 |
Missing (%) | 0.3% |
Memory size | 18.4 KiB |
Minimum | 2002-10-01 00:00:00 |
---|---|
Maximum | 2017-07-03 00:00:00 |
연구종료일
Text
MISSING
 
Distinct | 906 |
---|---|
Distinct (%) | 50.9% |
Missing | 557 |
Missing (%) | 23.8% |
Memory size | 18.4 KiB |
Length
Max length | 10 |
---|---|
Median length | 10 |
Mean length | 9.9275688 |
Min length | 1 |
Characters and Unicode
Total characters | 17681 |
---|---|
Distinct characters | 33 |
Distinct categories | 4 ? |
Distinct scripts | 2 ? |
Distinct blocks | 1 ? |
Unique
Unique | 619 ? |
---|---|
Unique (%) | 34.8% |
Sample
1st row | 2014-12-10 |
---|---|
2nd row | 2017-12-31 |
3rd row | 2017-03-01 |
4th row | 2018-04-16 |
5th row | 2020-09-30 |
Value | Count | Frequency (%) |
2016-12-31 | 38 | 2.1% |
2015-12-31 | 37 | 2.1% |
2015-07-31 | 26 | 1.5% |
2014-12-31 | 25 | 1.4% |
2017-12-31 | 25 | 1.4% |
2012-12-31 | 22 | 1.2% |
2013-12-31 | 16 | 0.9% |
2016-05-31 | 15 | 0.8% |
2018-12-31 | 15 | 0.8% |
2014-02-28 | 14 | 0.8% |
Other values (896) | 1548 |
Most occurring characters
Value | Count | Frequency (%) |
0 | 3736 | |
1 | 3565 | |
- | 3531 | |
2 | 2964 | |
3 | 1244 | 7.0% |
5 | 560 | 3.2% |
6 | 518 | 2.9% |
4 | 470 | 2.7% |
7 | 411 | 2.3% |
8 | 330 | 1.9% |
Other values (23) | 352 | 2.0% |
Most occurring categories
Value | Count | Frequency (%) |
Decimal Number | 14060 | |
Dash Punctuation | 3531 | 20.0% |
Lowercase Letter | 60 | 0.3% |
Uppercase Letter | 30 | 0.2% |
Most frequent character per category
Lowercase Letter
Value | Count | Frequency (%) |
e | 17 | |
c | 12 | |
a | 6 | 10.0% |
u | 5 | 8.3% |
p | 4 | 6.7% |
n | 4 | 6.7% |
y | 2 | 3.3% |
r | 2 | 3.3% |
b | 2 | 3.3% |
g | 2 | 3.3% |
Other values (4) | 4 | 6.7% |
Decimal Number
Value | Count | Frequency (%) |
0 | 3736 | |
1 | 3565 | |
2 | 2964 | |
3 | 1244 | 8.8% |
5 | 560 | 4.0% |
6 | 518 | 3.7% |
4 | 470 | 3.3% |
7 | 411 | 2.9% |
8 | 330 | 2.3% |
9 | 262 | 1.9% |
Uppercase Letter
Value | Count | Frequency (%) |
D | 11 | |
J | 5 | |
M | 4 | 13.3% |
S | 4 | 13.3% |
F | 2 | 6.7% |
A | 2 | 6.7% |
N | 1 | 3.3% |
O | 1 | 3.3% |
Dash Punctuation
Value | Count | Frequency (%) |
- | 3531 |
Most occurring scripts
Value | Count | Frequency (%) |
Common | 17591 | |
Latin | 90 | 0.5% |
Most frequent character per script
Latin
Value | Count | Frequency (%) |
e | 17 | |
c | 12 | |
D | 11 | |
a | 6 | 6.7% |
u | 5 | 5.6% |
J | 5 | 5.6% |
p | 4 | 4.4% |
n | 4 | 4.4% |
M | 4 | 4.4% |
S | 4 | 4.4% |
Other values (12) | 18 |
Common
Value | Count | Frequency (%) |
0 | 3736 | |
1 | 3565 | |
- | 3531 | |
2 | 2964 | |
3 | 1244 | 7.1% |
5 | 560 | 3.2% |
6 | 518 | 2.9% |
4 | 470 | 2.7% |
7 | 411 | 2.3% |
8 | 330 | 1.9% |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 17681 |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
0 | 3736 | |
1 | 3565 | |
- | 3531 | |
2 | 2964 | |
3 | 1244 | 7.0% |
5 | 560 | 3.2% |
6 | 518 | 2.9% |
4 | 470 | 2.7% |
7 | 411 | 2.3% |
8 | 330 | 1.9% |
Other values (23) | 352 | 2.0% |
주요결과변수
Text
Distinct | 2283 |
---|---|
Distinct (%) | 97.6% |
Missing | 0 |
Missing (%) | 0.0% |
Memory size | 18.4 KiB |
Length
Max length | 1024 |
---|---|
Median length | 345 |
Mean length | 102.65697 |
Min length | 9 |
Characters and Unicode
Total characters | 240012 |
---|---|
Distinct characters | 746 |
Distinct categories | 17 ? |
Distinct scripts | 4 ? |
Distinct blocks | 8 ? |
Unique
Unique | 2240 ? |
---|---|
Unique (%) | 95.8% |
Sample
1st row | Tadalafil 의 AUClast(AUClast of tadalafil)Tadalafil 의 Cmax(Cmax of tadalafil) |
---|---|
2nd row | ECOG performance state(활동력), GOOSS(식이 진행 사항), 임상적 식도 폐쇄에 대한 문진(ECOG performance state, GOOSS(Dietary progress), Esophageal obstruction) |
3rd row | 재유착율(reattachment rate) |
4th row | 숫자통증등급 (Numerical rating scales, NRS)(Numerical rating scales (NRS)) |
5th row | 최종 임상적 사건: 심혈관계 원인에 의한 사망, 비-치명적 심근경색, 비-치명적 뇌졸중, 비-관상동맥우회술 관련 TIMI 대출혈(Net clinical events: Death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, non-CABG related TIMI major bleeding) |
Value | Count | Frequency (%) |
of | 1531 | 4.4% |
and | 603 | 1.7% |
597 | 1.7% | |
the | 554 | 1.6% |
in | 333 | 1.0% |
scale | 240 | 0.7% |
및 | 233 | 0.7% |
후 | 212 | 0.6% |
rate | 178 | 0.5% |
score | 170 | 0.5% |
Other values (11498) | 29832 |
Most occurring characters
Value | Count | Frequency (%) |
32142 | 13.4% | |
e | 16627 | 6.9% |
a | 12686 | 5.3% |
i | 11672 | 4.9% |
t | 11369 | 4.7% |
o | 10939 | 4.6% |
n | 10510 | 4.4% |
r | 9203 | 3.8% |
s | 8603 | 3.6% |
c | 6454 | 2.7% |
Other values (736) | 109807 |
Most occurring categories
Value | Count | Frequency (%) |
Lowercase Letter | 137575 | |
Other Letter | 38950 | 16.2% |
Space Separator | 32146 | 13.4% |
Uppercase Letter | 14000 | 5.8% |
Close Punctuation | 5035 | 2.1% |
Open Punctuation | 5008 | 2.1% |
Other Punctuation | 2950 | 1.2% |
Decimal Number | 2907 | 1.2% |
Dash Punctuation | 1242 | 0.5% |
Math Symbol | 94 | < 0.1% |
Other values (7) | 105 | < 0.1% |
Most frequent character per category
Other Letter
Value | Count | Frequency (%) |
의 | 1386 | 3.6% |
도 | 931 | 2.4% |
수 | 723 | 1.9% |
시 | 641 | 1.6% |
이 | 636 | 1.6% |
혈 | 571 | 1.5% |
지 | 538 | 1.4% |
상 | 525 | 1.3% |
증 | 516 | 1.3% |
기 | 515 | 1.3% |
Other values (624) | 31968 |
Lowercase Letter
Value | Count | Frequency (%) |
e | 16627 | |
a | 12686 | 9.2% |
i | 11672 | 8.5% |
t | 11369 | 8.3% |
o | 10939 | 8.0% |
n | 10510 | 7.6% |
r | 9203 | 6.7% |
s | 8603 | 6.3% |
c | 6454 | 4.7% |
l | 6203 | 4.5% |
Other values (21) | 33309 |
Uppercase Letter
Value | Count | Frequency (%) |
C | 1774 | |
A | 1588 | 11.3% |
S | 1378 | 9.8% |
T | 842 | 6.0% |
D | 797 | 5.7% |
I | 771 | 5.5% |
P | 722 | 5.2% |
M | 703 | 5.0% |
R | 698 | 5.0% |
E | 549 | 3.9% |
Other values (17) | 4178 |
Other Punctuation
Value | Count | Frequency (%) |
, | 1984 | |
. | 274 | 9.3% |
/ | 228 | 7.7% |
: | 219 | 7.4% |
% | 109 | 3.7% |
? | 38 | 1.3% |
' | 35 | 1.2% |
; | 20 | 0.7% |
& | 19 | 0.6% |
" | 18 | 0.6% |
Other values (2) | 6 | 0.2% |
Decimal Number
Value | Count | Frequency (%) |
1 | 700 | |
2 | 552 | |
0 | 468 | |
3 | 271 | 9.3% |
4 | 239 | 8.2% |
5 | 226 | 7.8% |
8 | 144 | 5.0% |
6 | 115 | 4.0% |
9 | 103 | 3.5% |
7 | 89 | 3.1% |
Math Symbol
Value | Count | Frequency (%) |
~ | 22 | |
≥ | 18 | |
< | 14 | |
+ | 12 | |
> | 9 | |
= | 7 | 7.4% |
≤ | 7 | 7.4% |
∞ | 4 | 4.3% |
± | 1 | 1.1% |
Other Symbol
Value | Count | Frequency (%) |
● | 4 | |
△ | 3 | |
° | 3 | |
ⓡ | 2 |
Close Punctuation
Value | Count | Frequency (%) |
) | 5002 | |
] | 32 | 0.6% |
〉 | 1 | < 0.1% |
Space Separator
Value | Count | Frequency (%) |
32142 | ||
4 | < 0.1% |
Open Punctuation
Value | Count | Frequency (%) |
( | 4975 | |
[ | 33 | 0.7% |
Final Punctuation
Value | Count | Frequency (%) |
’ | 41 | |
” | 2 | 4.7% |
Initial Punctuation
Value | Count | Frequency (%) |
“ | 19 | |
‘ | 6 | 24.0% |
Letter Number
Value | Count | Frequency (%) |
Ⅶ | 4 | |
Ⅱ | 2 |
Other Number
Value | Count | Frequency (%) |
½ | 3 | |
② | 1 | 25.0% |
Modifier Symbol
Value | Count | Frequency (%) |
^ | 2 | |
` | 1 |
Dash Punctuation
Value | Count | Frequency (%) |
- | 1242 |
Connector Punctuation
Value | Count | Frequency (%) |
_ | 12 |
Most occurring scripts
Value | Count | Frequency (%) |
Latin | 151498 | |
Common | 49481 | 20.6% |
Hangul | 38950 | 16.2% |
Greek | 83 | < 0.1% |
Most frequent character per script
Hangul
Value | Count | Frequency (%) |
의 | 1386 | 3.6% |
도 | 931 | 2.4% |
수 | 723 | 1.9% |
시 | 641 | 1.6% |
이 | 636 | 1.6% |
혈 | 571 | 1.5% |
지 | 538 | 1.4% |
상 | 525 | 1.3% |
증 | 516 | 1.3% |
기 | 515 | 1.3% |
Other values (624) | 31968 |
Latin
Value | Count | Frequency (%) |
e | 16627 | 11.0% |
a | 12686 | 8.4% |
i | 11672 | 7.7% |
t | 11369 | 7.5% |
o | 10939 | 7.2% |
n | 10510 | 6.9% |
r | 9203 | 6.1% |
s | 8603 | 5.7% |
c | 6454 | 4.3% |
l | 6203 | 4.1% |
Other values (44) | 47232 |
Common
Value | Count | Frequency (%) |
32142 | ||
) | 5002 | 10.1% |
( | 4975 | 10.1% |
, | 1984 | 4.0% |
- | 1242 | 2.5% |
1 | 700 | 1.4% |
2 | 552 | 1.1% |
0 | 468 | 0.9% |
. | 274 | 0.6% |
3 | 271 | 0.5% |
Other values (42) | 1871 | 3.8% |
Greek
Value | Count | Frequency (%) |
τ | 44 | |
γ | 13 | 15.7% |
α | 12 | 14.5% |
β | 10 | 12.0% |
Δ | 2 | 2.4% |
λ | 2 | 2.4% |
Most occurring blocks
Value | Count | Frequency (%) |
ASCII | 200849 | |
Hangul | 38950 | 16.2% |
None | 100 | < 0.1% |
Punctuation | 68 | < 0.1% |
Math Operators | 29 | < 0.1% |
Geometric Shapes | 7 | < 0.1% |
Number Forms | 6 | < 0.1% |
Enclosed Alphanum | 3 | < 0.1% |
Most frequent character per block
ASCII
Value | Count | Frequency (%) |
32142 | ||
e | 16627 | 8.3% |
a | 12686 | 6.3% |
i | 11672 | 5.8% |
t | 11369 | 5.7% |
o | 10939 | 5.4% |
n | 10510 | 5.2% |
r | 9203 | 4.6% |
s | 8603 | 4.3% |
c | 6454 | 3.2% |
Other values (77) | 70644 |
Hangul
Value | Count | Frequency (%) |
의 | 1386 | 3.6% |
도 | 931 | 2.4% |
수 | 723 | 1.9% |
시 | 641 | 1.6% |
이 | 636 | 1.6% |
혈 | 571 | 1.5% |
지 | 538 | 1.4% |
상 | 525 | 1.3% |
증 | 516 | 1.3% |
기 | 515 | 1.3% |
Other values (624) | 31968 |
None
Value | Count | Frequency (%) |
τ | 44 | |
γ | 13 | 13.0% |
α | 12 | 12.0% |
β | 10 | 10.0% |
· | 5 | 5.0% |
4 | 4.0% | |
½ | 3 | 3.0% |
° | 3 | 3.0% |
Δ | 2 | 2.0% |
λ | 2 | 2.0% |
Other values (2) | 2 | 2.0% |
Punctuation
Value | Count | Frequency (%) |
’ | 41 | |
“ | 19 | |
‘ | 6 | 8.8% |
” | 2 | 2.9% |
Math Operators
Value | Count | Frequency (%) |
≥ | 18 | |
≤ | 7 | 24.1% |
∞ | 4 | 13.8% |
Number Forms
Value | Count | Frequency (%) |
Ⅶ | 4 | |
Ⅱ | 2 |
Geometric Shapes
Value | Count | Frequency (%) |
● | 4 | |
△ | 3 |
Enclosed Alphanum
Value | Count | Frequency (%) |
ⓡ | 2 | |
② | 1 |
연구현황 | 연구종류 | 임상시험단계 | 중재종류 | |
---|---|---|---|---|
연구현황 | 1.000 | 0.122 | 0.195 | 0.184 |
연구종류 | 0.122 | 1.000 | NaN | NaN |
임상시험단계 | 0.195 | NaN | 1.000 | 0.587 |
중재종류 | 0.184 | NaN | 0.587 | 1.000 |
중재종류 | 연구현황 | 임상시험단계 | 연구종류 | |
---|---|---|---|---|
중재종류 | 1.000 | 0.076 | 0.269 | 1.000 |
연구현황 | 0.076 | 1.000 | 0.105 | 0.130 |
임상시험단계 | 0.269 | 0.105 | 1.000 | 1.000 |
연구종류 | 1.000 | 0.130 | 1.000 | 1.000 |
연구현황 | 연구종류 | 임상시험단계 | 중재종류 | |
---|---|---|---|---|
연구현황 | 1.000 | 0.130 | 0.105 | 0.076 |
연구종류 | 0.130 | 1.000 | 1.000 | 1.000 |
임상시험단계 | 0.105 | 1.000 | 1.000 | 0.269 |
중재종류 | 0.076 | 1.000 | 0.269 | 1.000 |
연구현황 | 연구정보 | 연구의뢰자 | 연구비지원기관 | 연구종류 | 임상시험단계 | 중재종류 | 등록번호 | 연구고유번호 | 연구대상/질환 | 등록일 | 최종갱신일 | 첫환자등록일자 | 연구종료일 | 주요결과변수 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 연구종결(Completed) | 건강한 남성 자원자에서 tadalafil 20 mg 정제와 tadalafil 20 mg 구강용해필름의 안전성과 약동학을 비교평가하기 위한 무작위배정, 공개, 단회 투여, 2X2 교차임상시험 - A randomized, open-label, single-dosing, two-treatment, two-sequence, two-period, 2x2 crossover study to evaluate the safety and pharmacokinetics of tadalafil 20 mg tablet and tadalafil 20 mg Oral Dissolving Film in healthy male volunteers | 충남대학교병원 | (주)씨엘팜(CLPharm) | 중재연구(Interventional Study) | Phase1 | 의약품(Drug) | KCT0002360 | CNUH 2014-08-014 | penile erection | 2017-06-15 | 2017-05-29 | 2014-10-02 | 2014-12-10 | Tadalafil 의 AUClast(AUClast of tadalafil)Tadalafil 의 Cmax(Cmax of tadalafil) |
1 | 모집 중(Recruiting) | 악성 식도 협착에서 자가 팽창형 금속제 스텐트의 유용성 : 새롭게 디자인 된 스텐트를 이용한 전향적 연구 - Usefulness of self-expanding metallic stent in malignant esophageal stricture: Prospective study using anti-migration stent newly-redesigned | 재단법인아산사회복지재단 서울아산병원 | 재단법인아산사회복지재단 서울아산병원(Asan Medical Center) | 중재연구(Interventional Study) | Phase1 | 의료기구(Medical Device) | KCT0002359 | 2016-0471 | Obstructive, Stents | 2017-06-15 | 2017-06-15 | 2017-06-01 | 2017-12-31 | ECOG performance state(활동력), GOOSS(식이 진행 사항), 임상적 식도 폐쇄에 대한 문진(ECOG performance state, GOOSS(Dietary progress), Esophageal obstruction) |
2 | 연구종결(Completed) | 열공망막박리에서 충전물로서 공기를 사용한 결과 - Results of Exclusively Using Air as Gas Tamponade in Rhegmatogenous Retinal Detachment | 부산대학교병원 | 부산대학교병원(Pusan National University Hospital) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 시술/수술(Procedure/Surgery) | KCT0002358 | H-1612-005-049 | Retinal Detachment | 2017-06-15 | 2017-05-24 | 2016-12-25 | 2017-03-01 | 재유착율(reattachment rate) |
3 | 모집 중(Recruiting) | 유방암 환자로 항암치료에 수반되는 말초신경병증 환자에게 케어밴드(CarebandR)의 사용에 따른 효과 및 안전성 비교를 위한 단일기관, 무작위배정, 대조제품비교, 단일눈가림, 연구자 임상시험 - A Randomized, Single-blind, Placebo-controlled, Single center, Investigator Initiated Trial to Evaluate the Efficacy and Safety of CarebandR for Chemotherapy Induced Peripheral Neuropathy Subjects | 충남대학교 | 보건복지부(Ministry of Health & Welfare) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 의료기구(Medical Device) | KCT0002357 | CNUH 2016-11-020-004 | Breast Neoplasms Peripheral Nervous System Diseases | 2017-06-13 | 2017-05-24 | 2017-04-28 | 2018-04-16 | 숫자통증등급 (Numerical rating scales, NRS)(Numerical rating scales (NRS)) |
4 | 모집 중(Recruiting) | 경피적 관상동맥 중재술 및 프라수그렐 투여를 받은 급성 관상동맥 증후군 환자에서 1년간의 임상적 결과를 평가하기 위한 다기관, 비-중재적 관찰연구 - A multicenter, non-interventional observational study to evaluate 1-year clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) and Prasugrel therapy. | 서울대학교병원 | 한국다이이찌산쿄 주식회사(Daiichi-Sankyo Korea) | 관찰연구(Observational Study) | <NA> | <NA> | KCT0002356 | EFT-OS-16-01 | Acute Coronary Syndrome | 2017-06-13 | 2017-05-23 | 2017-03-09 | 2020-09-30 | 최종 임상적 사건: 심혈관계 원인에 의한 사망, 비-치명적 심근경색, 비-치명적 뇌졸중, 비-관상동맥우회술 관련 TIMI 대출혈(Net clinical events: Death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, non-CABG related TIMI major bleeding) |
5 | 모집 중(Recruiting) | 어깨 관절경 수술 후 통증에 대한 침스밴드의 효과를 평가하기 위한 무작위배정 탐색임상시험 - A randomized exploratory clinical trial to evaluate the effectiveness of the chimsband therapy for pain after shoulder arthroscopic surgery | 동신대학교 | 한국한의학연구원(Korea Institute of Oriental Medicine) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 의료기구(Medical Device) | KCT0002355 | KE1601 | 어깨 관절경 수술 후 어깨부위 통증을 호소하는 자 | 2017-06-13 | 2017-05-24 | 2017-05-16 | <NA> | 시각상사척도(Visual Analog Scale (VAS)) |
6 | 연구종결(Completed) | 내시경적 역행성 담췌관조영술 4시간 후 임상 평가를 바탕으로 한 조기 경구식이의 임상적 안전성과 환자 만족도 분석: 무작위, 전향적 연구 - Clinical safety and patient satisfaction of early re-feeding based on evaluation at 4 hours after endoscopic retrograde cholangio-pancreatography: A prospective randomized controlled trial | 한림대학교동탄성심병원 | 한림대학교동탄성심병원(Hallym University Medical Center-Dongtan) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 시술/수술(Procedure/Surgery) | KCT0002354 | 2015-238-I | all disease requiring ERCP | 2017-06-13 | 2017-05-24 | 2015-07-22 | 2017-04-21 | ERCP 시술 후 시술관련 급성췌장염의 발생빈도(the incidence of post ERCP pancreatitis) |
7 | 모집 중(Recruiting) | 복강경하 담낭절제술을 시행받는 남자환자에서 마취 후 기관내튜브 제거 중 기침 예방을 위한 remifentanil의 적정 효과처 농도에 나이가 미치는 영향 - Effects of age on the optimal effect-site concentration of remifentanil for preventing cough during anesthetic emergence in male patients undergoing laparoscopic cholecystectomy | 아주대학교 | 아주대학교병원(Ajou University Hospital) | 중재연구(Interventional Study) | Phase4 | 기타(Others) | KCT0002353 | AJIRB-MED-OBS-16-146 | laparoscopic cholecystectomy 시행받는 20-50세와 65-75세 남자 환자 | 2017-06-13 | 2017-05-24 | 2016-06-27 | 2017-12-31 | 마취로 부터 각성시 발관 5분 이내의 기침 유무(presence or absence of cough after extubation within 5 min) |
8 | 모집 중(Recruiting) | 비디오 투시 삼킴 검사 중 인두너비 측정을 통한 흡인 예측 - Prediction of aspiration using pharyngeal width taken during VFSS | 한림대학교 | 한림대학교(Hallym University) | 관찰연구(Observational Study) | <NA> | <NA> | KCT0002352 | 2017-I040 | Dysphagia, Cerebral infarction, Cerebral hemorrhage | 2017-06-12 | 2017-05-23 | 2017-06-01 | 2018-05-31 | 인두 너비(Pharyngeal width) |
9 | 연구종결(Completed) | 복부근육 활동도 측정을 위한 압력 측정 기기의 선행적, 탐색적 연구 - Novel pressure sensor device to measure abdominal muscle activities: a preliminary and exploratory study | 서울대학교병원 | 서울대학교병원(Seoul National University Hospital) | 관찰연구(Observational Study) | <NA> | <NA> | KCT0002351 | H-1410-059-618 | low back pain | 2017-06-09 | 2017-05-23 | 2014-11-01 | 2015-03-31 | 표면 근전도의 출력과 본 연구에서 개발한 압력센서 출력간의 상관관계(Correlation coefficient between surface electromyogram and output of the pressure sensor developed in thist study) |
연구현황 | 연구정보 | 연구의뢰자 | 연구비지원기관 | 연구종류 | 임상시험단계 | 중재종류 | 등록번호 | 연구고유번호 | 연구대상/질환 | 등록일 | 최종갱신일 | 첫환자등록일자 | 연구종료일 | 주요결과변수 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2328 | 모집 중(Recruiting) | 췌장 절제술을 시행 받은 환자에서 췌장효소 보충제제의 투여가 삶의 질과 영양학적 지표에 미치는 영향에 대한 전향적 연구 - Prospective study for the effects of pancreatic enzyme replacement therapy on quality of life and nutritional assessment after pancreas resection | 서울대학교 | 서울대학교(Seoul National University) | 중재연구(Interventional Study) | Phase3 | 의약품(Drug) | KCT0000010 | H-0801-030-232 | Malignant neoplasm of ampulla of Vater(바터 팽대부 악성신생물),Benign neoplasMalignant neoplasm of ampulla of Vater(바터 팽대부 악성신생물),Benign neoplasm of pancreas(췌장(이자) 양성신생물),Cyst of pancreas(췌장(이자)의 낭종),Malignant neoplasm of pancreas(췌장(이자)의 악성신생물),Neoplasm of uncertain or unknown behavior of pancreas(췌장(이자)의 행동양식 불명 또는 미상의 신생물),Benign neoplasm of endocrine pancreas(내분비 췌장(이자) 양성신생물),Carcinoma in situ of pancreas(췌장(이자) 상피내 암종),Malignant neoplasm of duodenum(십이지장 악성신생물),Malignant neoplasm of common bile duct(총 쓸개관(총담관)의 악성신생물) | 2010-06-30 | 2010-06-28 | 2008-09-08 | <NA> | 삶의 질(quality of life) |
2329 | 연구종결(Completed) | 초발 정신병 환자에서 Paliperidone의 효과와 안정성: 개방형, 전향적, 다기관 연구 - Efficacy and Safety of Paliperidone in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study | 전북대학교병원 | 전북대학교병원(Chonbuk National University Hospital) | 중재연구(Interventional Study) | Phase4 | 의약품(Drug) | KCT0000009 | CBIRB0912-141 | Schizophrenia(정신분열병) | 2010-06-28 | 2015-04-16 | 2010-03-15 | 2014-02-27 | PANSS total score, SANS, CGI, CAI(Cognitive Assessment Interview) (PANSS total score, SANS, CGI, CAI(Cognitive Assessment Interview) ) |
2330 | 연구종결(Completed) | 수술적 및/또는 비수술적 치료를 받은 간세포암 환자를 대상으로 대조군과 크레아박스-에치씨씨(자가유래 성숙화 수지상세포) 투여군의 유효성과 안전성을 비교하여평가하기 위한 공개, 무작위배정, 다기관 제2상 임상연구 - A Opened, Randomized, Multi-centered Phase II study on the efficacy and safety of CreaVax-HCC(Autologous Mature Dendritic Cells)in patients with hepatocellular carcinoma for comparing after a operation and/or non-operation therapy | 서울대학교병원 | 한국보건산업진흥원(Korea Health Industry Development Institute) | 중재연구(Interventional Study) | Phase2 | 생물학적제제/백신(Biological/Vaccine) | KCT0000008 | CreaVax-HCC-002 | Liver cell carcinoma(간세포암종) | 2010-06-28 | 2014-02-03 | 2010-06-15 | 2013-09-27 | 무재발생존율(Recurrence free survival rate) |
2331 | 모집 중(Recruiting) | 술중 지속적으로 투여된 저농도의 esmolol이 흡입마취제와 마약제제의 요구량에 미치는 효과 - The effect of continuous infusion of low-dose esmolol on the requirement of inhalation anesthetics and opioid during surgery | 가톨릭대학교서울성모병원 | 없음(none) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 의약품(Drug) | KCT0000007 | KC09MISI0324-2 | Not Applicable( 해당사항없음) | 2010-06-28 | 2010-06-25 | 2009-12-21 | <NA> | remifentanil의 평균농도(average effect-site concentration of remifentanil)remifentanil의 적정농도에 대한 평균농도의 비(ratio of average to adequate effect-site concentration of remifentanil)단위시간당 remifentanil 효과처농도의 상승/하강 횟수(frequency of increase and decrease in the effect-site concentration of remifentanil per hour) |
2332 | 모집 중(Recruiting) | 초발 정신병 환자에서 Aripiprazole의 효과와 안정성: 개방형, 전향적, 다기관 연구 - Efficacy and Safety of Aripiprazole in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study | 전북대학교병원 | 전북대학교병원(Chonbuk National University Hospital) | 중재연구(Interventional Study) | Phase4 | 의약품(Drug) | KCT0000006 | CBIRB0909-97 | Schizophrenia(정신분열병) | 2010-06-23 | 2010-06-28 | 2009-11-05 | <NA> | PANSS total score, SANS, CGI, CAI(Cognitive Assessment Interview)(PANSS total score, SANS, CGI, CAI(Cognitive Assessment Interview)) |
2333 | 모집 중(Recruiting) | 복강경하 산부인과 수술을 받는 환자를 대상으로 술중 지속적으로 투여된 저농도의 esmolol이 흡입마취제와 마약제제의 요구량에 미치는 효과에 관한 전향적, 무작위배정, 2개군 시험 - Prospective, randomized, two-arm parallel group trial for the sparing effects of low-dose esmolol on inhalation anesthetics in patients undergoing laparoscopic gynecologic surgery | 가톨릭대학교서울성모병원 | 없음(None) | 중재연구(Interventional Study) | 해당사항없음(Not applicable) | 의약품(Drug) | KCT0000005 | KC09MISI0324-1 | Not Applicable( 해당사항없음) | 2010-06-23 | 2010-06-23 | 2009-12-21 | <NA> | 약물주입을 전후로 한 sevoflurane의 흡입 농도의 차이 (The difference between the input concentration before infusing the study drug and the input concentration after infusing the study drug) |
2334 | 모집 중(Recruiting) | 다제내성결핵 접촉자의 접촉 후 2년 간의 결핵 발병률에 대한 다기관 전향적 코호트 연구 - Multicenter, prospective cohort study about incidence of tuberculosis for 2 years after contact to patients with multidrug-resistant tuberculosis | 서울아산병원 | 대한 결핵 및 호흡기 학회(The Korean Academy of Tuberculosis and Respiratory Diseases) | 관찰연구(Observational Study) | <NA> | <NA> | KCT0000004 | 2010-0014 | Not Applicable( 해당사항없음) | 2010-06-09 | 2010-06-10 | 2010-02-16 | <NA> | 결핵 발생률(incidence of tuberculosis ) |
2335 | 모집 중(Recruiting) | 유방전절제 후 Guardix-sol.의 상지기능 장애 예방에 대한 연구 - The clinical efficacy of Guardix-sol. for the prevention of arm and shoulder morbidity after total mastectomy | 분당서울대학교병원 | 한미메디케어(Hanmimedicare) | 중재연구(Interventional Study) | Phase4 | 의료기구(Medical Device) | KCT0000003 | 06-2009081 | Carcinoma in situ of breast(유방의 상피내 암종),Malignant neoplasm of breast(C50)(유방의 악성신생물) | 2010-06-09 | 2010-06-09 | 2009-07-13 | <NA> | 어깨관절 운동 범위(Active range of motion of shoulder) |
2336 | 대상자 모집 전(Not yet recruiting) | 암 생존 환자에서의 지식, 태도, 행동에 관한 건강교육자료에 대한 효과의 무작위적 시험 - A Randomized Controlled Trial on the Effect of Intervention With Health Educational Material on Knowledge, Attitude, and Behavior in Cancer Survivors | 국립암센터 | 국립암센터(National Cancer Center) | 중재연구(Interventional Study) | Phase2 | 행동요인(Behavioral) | KCT0000002 | NCS-09-266 | Malignant neoplasm of breast(C50)(유방의 악성신생물),Malignant neoplasm of stomach(위의 악성신생물),Malignant neoplasm of thyroid gland(갑상샘의 악성신생물),Malignant neoplasm of colon(결장의 악성신생물) | 2010-02-11 | 2011-01-18 | 2009-08-01 | 10-Dec | 행동 스크리닝 (Screening behavior for second primary cancer) |
2337 | 모집 중(Recruiting) | 심혈관 질환의 여러 위험 인자들을 갖고 있는 환자에서 주요 심혈관계 사건의 위험성 감소에 대한 피타바스타틴 2mg 1일 1회 용법의 무작위배정, 다기관, open-labeled, 2개군, 평행군 시험 - Randomized, multicenter, open-labeled, two-arm parallel group trial of pitavastatin 2 mg OD for reducing the risk of major cardiovascular events in patients with clustering cardiovascular risk factors | 울산대학교 | 질병관리본부(Korea Centers for Disease Control and Prevention) | 중재연구(Interventional Study) | Phase3 | 의약품(Drug) | KCT0000001 | 2009-0074 | Hyperlipidemia, unspecified(상세불명의 고지혈증),Hypertension, essential(본태성 고혈압),Diabetes mellitus(E10-E14)(당뇨병) | 2010-02-11 | 2010-04-07 | 2009-05-14 | <NA> | 임의의 심근경색, 임의의 뇌졸중, 심혈관계 사망, 심혈관계 원인으로 인한 입원(불안정성 협심증, 이로가성허혈성 발작, 유의한 혈관의 협착의 발생 또는 혈관재생술/혈관재개통술)(Myocardial infarction, stroke, Cardiovascular death, Hospitalization due to unstable angina, TIA, the development of atherosclerotic) |